Observational studies on macroprolactin in a routine clinical laboratory
It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin. A retrospective study of macroprolactin wa...
Saved in:
Published in | Clinical chemistry and laboratory medicine Vol. 56; no. 8; pp. 1259 - 1262 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Germany
De Gruyter
26.07.2018
Walter De Gruyter & Company |
Subjects | |
Online Access | Get full text |
ISSN | 1434-6621 1437-4331 1437-4331 |
DOI | 10.1515/cclm-2018-0074 |
Cover
Abstract | It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin.
A retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation.
The incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])).
The presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously. |
---|---|
AbstractList | It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin. Methods: A retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation. Results: The incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])). Conclusions: The presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously. It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin. A retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation. The incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])). The presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously. It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin.BACKGROUNDIt is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our experience of macroprolactin to determine the incidence and the natural history of macroprolactin.A retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation.METHODSA retrospective study of macroprolactin was made in a large clinical laboratory. Macroprolactin was measured on those samples where it is requested and where the total prolactin is >1000 mIU/L. Prolactin was measured using the Siemens Centaur and macroprolactin was measured following polyethylene glycol (PEG)-precipitation.The incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])).RESULTSThe incidence of macroprolactin in samples where the total prolactin was >1000 mIU/L was 36/670 (5.4%). During this period, 12,064 samples were received for prolactin analysis. Over the period since 2006, 22 subjects had a sample with an isolated macroprolactin measurement followed by another sample without macroprolactin after a median period of 0.46 years. Twenty-five subjects had multiple consecutive measurements of macroprolactin lasting a median period of 2.1 years. Fourteen subjects had more than six samples which had been subjected to PEG precipitation. In these subjects, the reproducibility of PEG precipitation over a median of 6 years was 1.1% CV (recovery 75% [26-110] (median [range])).The presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously.CONCLUSIONSThe presence of macroprolactin can change over time and we cannot advise that once a test for macroprolactinemia has been performed that it is not necessary to repeat the investigation if a subsequent sample is hyperprolactinemic; nor can one assume that macroprolactin will not develop even if it has been excluded previously. |
Author | Desborough, Robert A. Lippiatt, Carys M. Gibbons, Stephen G. Barth, Julian H. |
Author_xml | – sequence: 1 givenname: Julian H. surname: Barth fullname: Barth, Julian H. email: julian.barth@nhs.net organization: Blood Sciences, Leeds General Infirmary, Leeds LS 3EX, UK, Phone: 0113 392 2584, Fax: 0113 392 5174 – sequence: 2 givenname: Carys M. surname: Lippiatt fullname: Lippiatt, Carys M. organization: Blood Sciences, Leeds General Infirmary, Leeds, UK – sequence: 3 givenname: Stephen G. surname: Gibbons fullname: Gibbons, Stephen G. organization: Blood Sciences, Leeds General Infirmary, Leeds, UK – sequence: 4 givenname: Robert A. surname: Desborough fullname: Desborough, Robert A. organization: Blood Sciences, Leeds General Infirmary, Leeds, UK |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29630507$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kc1r3DAQxUVJaZJtrzkGQy65eKtvWYceQkiaQiCX5GxkeVy0yNZWkhP2v4-cTVtYWhDMO_yemHnvFB1NYQKEzgheE0HEV2v9WFNMmhpjxT-gE8KZqjlj5OhN81pKSo7RaUobjIkQXH1Cx1RLhgVWJ-juoUsQn012YTK-SnnuHaQqTNVobAzbGLyx2U1VeaaKYS4aKuvd5GzhvelCNDnE3Wf0cTA-wZf3uUJPtzeP13f1_cP3H9dX97XlVOSa9xR0A_3QKCU6qbkauDbadkrqZhh6rjtQPeOKSCCsLMkYl8Ckkr3h2ABbocv9v2W1XzOk3I4uWfDeTBDm1FJMmWJclAtX6OIA3YQ5ljMXSipNBMW4UOfv1NyN0Lfb6EYTd-3vjAqw3gMlj5QiDH8QgtulhHYpoV1KaJcSioEfGKzLbwnnaJz_v-3b3vZifIbYw88474r4u_W_jUI2hArNXgGeKp5o |
CitedBy_id | crossref_primary_10_1016_j_ando_2024_101677 crossref_primary_10_1515_almed_2024_0010 crossref_primary_10_1515_almed_2024_0098 crossref_primary_10_3343_alm_2022_42_1_3 crossref_primary_10_1093_labmed_lmac136 crossref_primary_10_1186_s12902_021_00861_z crossref_primary_10_1515_cclm_2020_0858 crossref_primary_10_1055_a_0902_4439 crossref_primary_10_3390_metabo15010009 crossref_primary_10_3390_ijerph17218199 crossref_primary_10_1016_j_cca_2023_117358 crossref_primary_10_1515_cclm_2019_0898 crossref_primary_10_1111_cen_15051 |
Cites_doi | 10.1258/000456302760042128 10.3109/09513590.2014.887672 10.1210/jc.2010-0114 10.1530/EJE-14-1073 10.1093/clinchem/46.6.884 10.1210/jc.2004-2234 10.1373/49.9.1504 10.1111/j.1365-2265.2009.03570.x 10.1210/jc.2001-011943 10.1093/clinchem/47.2.331 10.1530/EJE-11-1007 10.1258/acb.2009.009059 |
ContentType | Journal Article |
Copyright | Copyright Walter De Gruyter & Company 2018 |
Copyright_xml | – notice: Copyright Walter De Gruyter & Company 2018 |
DBID | AAYXX CITATION NPM 7QO 7T7 7TK 7U7 8FD C1K FR3 P64 7X8 |
DOI | 10.1515/cclm-2018-0074 |
DatabaseName | CrossRef PubMed Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Toxicology Abstracts Technology Research Database Environmental Sciences and Pollution Management Engineering Research Database Biotechnology and BioEngineering Abstracts MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed Biotechnology Research Abstracts Technology Research Database Toxicology Abstracts Engineering Research Database Industrial and Applied Microbiology Abstracts (Microbiology A) Neurosciences Abstracts Biotechnology and BioEngineering Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | Biotechnology Research Abstracts PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry |
EISSN | 1437-4331 |
EndPage | 1262 |
ExternalDocumentID | 29630507 10_1515_cclm_2018_0074 10_1515_cclm_2018_00745681259 |
Genre | Journal Article |
GroupedDBID | --- 0R~ 0~D 29B 354 36B 4.4 53G 5GY 5RE AAAEU AABBZ AAFPC AAGVJ AAILP AALGR AAONY AAOQK AAOWA AAPJK AAQCX AARRE AASQH AAWFC AAXCG ABAOT ABAQN ABDRH ABFKT ABFQV ABIQR ABJNI ABLJU ABMIY ABPLS ABRDF ABRQL ABUVI ABWLS ABXMZ ABYBW ACDEB ACEFL ACGFS ACIWK ACMKP ACPMA ACPRK ACUND ACXLN ACYCL ACZBO ADDWE ADEQT ADGQD ADGYE ADNPR ADOZN AECWL AEDGQ AEGVQ AEICA AEJTT AEKEB AENEX AEQDQ AERZL AEXIE AFBAA AFBDD AFBQV AFCXV AFGDO AFGNR AFQUK AFRAH AFYRI AGBEV AHOVO AHVWV AHXUK AIERV AIKXB AIWOI AJATJ AJHHK AKXKS ALMA_UNASSIGNED_HOLDINGS ALUKF AMAVY ASYPN AZMOX BAKPI BBCWN BCIFA BWHEM CGQUA CS3 DSRVY DU5 EBS EJD EMOBN F5P FSTRU HZ~ IY9 KDIRW N9A O9- OBC OBS OEB OES OHH OVD P2P PQQKQ QD8 RDG SA. SLJYH TEORI UK5 WTRAM AAYXX CITATION ABVMU ALYBR NPM 7QO 7T7 7TK 7U7 8FD C1K FR3 P64 7X8 |
ID | FETCH-LOGICAL-c425t-4d2e98edf8775b6947f49a9cb7698ffd49be7d34716e133053346e3676da40ae3 |
ISSN | 1434-6621 1437-4331 |
IngestDate | Mon Sep 29 05:34:57 EDT 2025 Mon Jun 30 14:55:53 EDT 2025 Thu Apr 03 07:05:19 EDT 2025 Wed Oct 01 03:28:51 EDT 2025 Thu Apr 24 23:09:05 EDT 2025 Sat Sep 06 17:01:56 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | polyethyelene glycol macroprolactin prolactin |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c425t-4d2e98edf8775b6947f49a9cb7698ffd49be7d34716e133053346e3676da40ae3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 29630507 |
PQID | 2067915200 |
PQPubID | 105421 |
PageCount | 4 |
ParticipantIDs | proquest_miscellaneous_2023734596 proquest_journals_2067915200 pubmed_primary_29630507 crossref_primary_10_1515_cclm_2018_0074 crossref_citationtrail_10_1515_cclm_2018_0074 walterdegruyter_journals_10_1515_cclm_2018_00745681259 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-07-26 |
PublicationDateYYYYMMDD | 2018-07-26 |
PublicationDate_xml | – month: 07 year: 2018 text: 2018-07-26 day: 26 |
PublicationDecade | 2010 |
PublicationPlace | Germany |
PublicationPlace_xml | – name: Germany – name: Berlin |
PublicationTitle | Clinical chemistry and laboratory medicine |
PublicationTitleAlternate | Clin Chem Lab Med |
PublicationYear | 2018 |
Publisher | De Gruyter Walter De Gruyter & Company |
Publisher_xml | – name: De Gruyter – name: Walter De Gruyter & Company |
References | (ref171) 2016; 54 (ref71) 2003; 49 (ref31) 2014; 30 (ref41) 2013; 34 (ref51) 2010; 95 (ref141) 2001; 47 (ref151) 2009; 71 (ref61) 2012; 166 (ref251) 2009; 46 (ref91) 2002; 87 (ref311) 2001; 47 (ref301) 2005; 90 (ref231) 2012; 166 (ref21) 2016; 54 (ref161) 2002; 39 (ref281) 2017; 55 (ref271) 2016; 20 (ref121) 2015; 172 (ref191) 2016; 54 (ref101) 2016; 20 (ref201) 2014; 30 (ref111) 2017; 55 (ref331) 2002; 39 (ref131) 2005; 90 (ref221) 2010; 95 (ref241) 2003; 49 (ref211) 2013; 34 (ref291) 2015; 172 (ref01) 2016; 54 (ref321) 2009; 71 (ref11) 2000; 46 (ref81) 2009; 46 (ref261) 2002; 87 (ref181) 2000; 46 |
References_xml | – volume: 54 start-page: 519 year: 2016 ident: ref01 article-title: Macroprolactin: searching for a needle in a haystack? publication-title: Clin Chem Lab Med – volume: 39 start-page: 366 year: 2002 ident: ref161 article-title: Interference in immunoassay is an underestimated problem publication-title: Ann Clin Biochem doi: 10.1258/000456302760042128 – volume: 30 start-page: 385 year: 2014 ident: ref201 article-title: Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas publication-title: Gynecol Endocrinol doi: 10.3109/09513590.2014.887672 – volume: 34 start-page: 207 year: 2013 ident: ref211 article-title: Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up publication-title: Neuro Endocrinol Lett – volume: 39 start-page: 366 year: 2002 ident: ref331 article-title: Interference in immunoassay is an underestimated problem publication-title: Ann Clin Biochem doi: 10.1258/000456302760042128 – volume: 34 start-page: 207 year: 2013 ident: ref41 article-title: Macroprolactinemia in women with hyperprolactinemia: a 10-year follow-up publication-title: Neuro Endocrinol Lett – volume: 30 start-page: 385 year: 2014 ident: ref31 article-title: Coexistence of macroprolactinaemia and hyperprolactinaemia in women with oligo-/amenorrhoea is associated with high risk of pituitary adenomas publication-title: Gynecol Endocrinol doi: 10.3109/09513590.2014.887672 – volume: 95 start-page: 3268 year: 2010 ident: ref51 article-title: Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-0114 – volume: 55 start-page: 1744 year: 2017 ident: ref281 article-title: Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia publication-title: Clin Chem Lab Med – volume: 55 start-page: 1744 year: 2017 ident: ref111 article-title: Serum prolactin revisited: parametric reference intervals and cross platform evaluation of polyethylene glycol precipitation-based methods for discrimination between hyperprolactinemia and macroprolactinemia publication-title: Clin Chem Lab Med – volume: 54 start-page: 519 year: 2016 ident: ref171 article-title: Macroprolactin: searching for a needle in a haystack? publication-title: Clin Chem Lab Med – volume: 172 start-page: 687 year: 2015 ident: ref291 article-title: Macroprolactinoma: a biological diagnostic strategy from the study of 222 patients publication-title: Eur J Endocrinol doi: 10.1530/EJE-14-1073 – volume: 46 start-page: 884 year: 2000 ident: ref181 article-title: Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers publication-title: Clin Chem doi: 10.1093/clinchem/46.6.884 – volume: 54 start-page: 603 year: 2016 ident: ref191 article-title: A possible cause of the variable detectability of macroprolactin by different immunoassay systems publication-title: Clin Chem Lab Med – volume: 90 start-page: 3927 year: 2005 ident: ref131 article-title: The impact on clinical practice of routine screening for macroprolactin publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-2234 – volume: 49 start-page: 1504 year: 2003 ident: ref241 article-title: Frequent Misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia publication-title: Clin Chem doi: 10.1373/49.9.1504 – volume: 20 start-page: 1788 year: 2016 ident: ref271 article-title: A new criteria for screening macroprolactinaemia using polyethylene glycol treatment combined with different assays for prolactin publication-title: Eur Rev Med Pharmacol Sci – volume: 71 start-page: 702 year: 2009 ident: ref151 article-title: Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2009.03570.x – volume: 87 start-page: 5410 year: 2002 ident: ref261 article-title: Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2001-011943 – volume: 172 start-page: 687 year: 2015 ident: ref121 article-title: Macroprolactinoma: a biological diagnostic strategy from the study of 222 patients publication-title: Eur J Endocrinol doi: 10.1530/EJE-14-1073 – volume: 46 start-page: 884 year: 2000 ident: ref11 article-title: Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers publication-title: Clin Chem doi: 10.1093/clinchem/46.6.884 – volume: 90 start-page: 3927 year: 2005 ident: ref301 article-title: The impact on clinical practice of routine screening for macroprolactin publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2004-2234 – volume: 71 start-page: 702 year: 2009 ident: ref321 article-title: Macroprolactinaemia: prevalence and aetiologies in a large group of hospital workers publication-title: Clin Endocrinol (Oxf) doi: 10.1111/j.1365-2265.2009.03570.x – volume: 20 start-page: 1788 year: 2016 ident: ref101 article-title: A new criteria for screening macroprolactinaemia using polyethylene glycol treatment combined with different assays for prolactin publication-title: Eur Rev Med Pharmacol Sci – volume: 49 start-page: 1504 year: 2003 ident: ref71 article-title: Frequent Misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia publication-title: Clin Chem doi: 10.1373/49.9.1504 – volume: 47 start-page: 331 year: 2001 ident: ref141 article-title: Prolactin results for samples containing macroprolactin are method and sample dependent publication-title: Clin Chem doi: 10.1093/clinchem/47.2.331 – volume: 87 start-page: 5410 year: 2002 ident: ref91 article-title: Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2001-011943 – volume: 54 start-page: 603 year: 2016 ident: ref21 article-title: A possible cause of the variable detectability of macroprolactin by different immunoassay systems publication-title: Clin Chem Lab Med – volume: 166 start-page: 625 year: 2012 ident: ref231 article-title: The natural history of macroprolactinaemia publication-title: Eur J Endocrinol doi: 10.1530/EJE-11-1007 – volume: 47 start-page: 331 year: 2001 ident: ref311 article-title: Prolactin results for samples containing macroprolactin are method and sample dependent publication-title: Clin Chem doi: 10.1093/clinchem/47.2.331 – volume: 46 start-page: 501 year: 2009 ident: ref251 article-title: Macroprolactin on the Advia Centaur – experience with 409 patients over a 3 year period publication-title: Ann Clin Biochem doi: 10.1258/acb.2009.009059 – volume: 95 start-page: 3268 year: 2010 ident: ref221 article-title: Ten-year clinical follow-up of a cohort of 51 patients with macroprolactinemia establishes it as a benign variant publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2010-0114 – volume: 166 start-page: 625 year: 2012 ident: ref61 article-title: The natural history of macroprolactinaemia publication-title: Eur J Endocrinol doi: 10.1530/EJE-11-1007 – volume: 46 start-page: 501 year: 2009 ident: ref81 article-title: Macroprolactin on the Advia Centaur – experience with 409 patients over a 3 year period publication-title: Ann Clin Biochem doi: 10.1258/acb.2009.009059 |
SSID | ssj0015547 |
Score | 2.3014128 |
Snippet | It is now recommended that all samples with raised prolactin should be examined for the presence of macroprolactin. We performed a retrospective review of our... |
SourceID | proquest pubmed crossref walterdegruyter |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1259 |
SubjectTerms | Incidence Laboratories macroprolactin Observational studies polyethyelene glycol Polyethylene glycol Prolactin Reproducibility |
Title | Observational studies on macroprolactin in a routine clinical laboratory |
URI | https://www.degruyter.com/doi/10.1515/cclm-2018-0074 https://www.ncbi.nlm.nih.gov/pubmed/29630507 https://www.proquest.com/docview/2067915200 https://www.proquest.com/docview/2023734596 |
Volume | 56 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAZK databaseName: De Gruyter Complete Journal Package 2023 customDbUrl: eissn: 1437-4331 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0015547 issn: 1434-6621 databaseCode: AGBEV dateStart: 19950101 isFulltext: true titleUrlDefault: https://www.degruyterbrill.com providerName: Walter de Gruyter |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR1db9Mw0CqdBONhgvEVGChICB6QoUlsJ34cVbcK7eOlRX2LbMdBSFuydalQ-fWcHSdpWJEGUhVVjpWzfOfzfR9C72SY6ZwkGaZKK0yAhrCEixDD3R3EMRV0FJh859MzNp2Trwu6GAzWG1FLq0p-Ur-25pX8D1ZhDPBqsmT_AbPtR2EA_gN-4QkYhuedcHwuW5uqTfuwIYHG_H8pTGeuJaitwM5sLKP4uCxhJSBStrmQDv9lPyl63LxWTSs461_oJt92xwsXZWhyrYFdtM4nW_xBVE1gyfqmM70e_5CyrEV4F2fWNfkCVRhgme5BXei3M7k680SQGLtnnQPvOCqJ4i4tS28Zc2yYsg1ySzZ4KohgfCuzp7YuhlIXl7iGPKob_vSrap-dp0fzk5N0NlnM3l9dY9NwzDjmXfeVe2gnjBkLh2jn8PjL5FvrggI5y3bmadbqKn4C0M99kH2J5paa8hDt_bSRD5n-vlytq8bTbgWY2SO05zQP_7Amo8dooIt99GDcYHkf3T91iH2Cpj3K8h1l-WXh9ynLh5_wHWX5DWX5HbE8RfOjyWw8xa7nBlbAvStMslDzRGd5AidVMk7inHDBlYwZT_I8I1zqOItApGE6iCKbyc20KfuXCTISOnqGhkVZ6BfIjxnJeQLyTk4FiEqx5ExSlSnBMtASGPEQbvYtVa4gvemLcpEaxRT2OTX7nJp9Ts0-e-hDO_-qLsXy15kHDRpSd1xvUtOngAemypiH3ravYYuNh0wUulyZOWEUR4Ry5qHnNfpaUCFcVSPQnjzE_sBnB2P7cmyNP8pf3gHsK7TbHaIDNKyWK_0apN5KvnH0-Rv1gLB5 |
linkProvider | Walter de Gruyter |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwEB7RRSrtASiFNkBpKlXqyewmcez4CAi6bVl6gYpb5FdAYjepQqKK_vqONw-evbRSbrHjeGbsb_yYbwA-qtDYjCaGxNpqQtGGiEIgJIjdAeexjEeBi3eenLDxGf16Hp_fiYVx1yqNvSjrm6phSB2aQtduo6znGkAEHmo9naGCg4Q4DBxeVrPpM1jExQqjA1jc-7x_-KM_S0DAnKdYoREljIVBS934-DP3oemRv_kSln_Nj7D7_7uDREcroLs-NBdQrnbrSu3q3w_oHf-vk6uw3Dqq_l5jWa9gweZrsHTQ5Ydbg-eT9lj-NYy_q35zF-tcN3cT_SL3Z9KlCCtx_Yzzau7jI_2yQGPPrd8FZfqtIRblzTqcHR2eHoxJm6KBaBzsFaEmtCKxJktQsYoJyjMqpNCKM5FkmaFCWW4iREBmcTU8D_xl1rHEGUlH0kYbMMiL3L4FnzOaiQThMYslIitXgqlYGy2ZQaeSUQ9Ip51Ut_zlLo3GNHXrGJRX6uSVOnmlTl4efOrL_2yYO_5acrtTdtqO4OvU0dqLwJFSefChf40idgcqMrdF7cqEEY9oLJgHbxoj6ZsKcWYbobPtAXtgNbdtPP07c0q4WGz-a8X3sDQ-nRynx19Ovm3Bi8aAOAnZNgyqsrbv0Iuq1E47TP4A1b0XHg |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB5BKxU4tKUUSFtKkJA4ubtJHDs-9rVsCy0cKOIW-RUOtEmVTYTKr2e8cdIXXEDKLXYcz4z9je3xNwBvVWxsQTNDUm01oWhDRCEQEsTuiPNUpuPI3Xc-OWXTM3r8Le2jCWc-rNLY73V71XQMqSNT6dZtlA1cA4jAI63PL1DBUUYcBo4uTfEQFhHrM1x_Le6-3zv8OhwlIF7OM6zQhBLG4sgzN97_ym1kuuduPoHln_MT7OH3bgDRZAVU34Uu_uTHTtuoHf3rDrvjf_VxFZa9mxrudnb1FB7Ycg0e7ffZ4dZg6cQfyj-D6Sc1bO1inVkXmRhWZXghXYKwGlfPOKuWIT4yrCs09dKG_ZXM0JthVV-tw9nk8Mv-lPgEDUTjUG8INbEVmTVFhmpVTFBeUCGFVpyJrCgMFcpykyD-MYtr4fm1X2YdR5yRdCxt8hwWyqq0LyHkjBYiQ3AsUom4ypVgKtVGS2bQpWQ0ANIrJ9eevdwl0TjP3SoGxZU7ceVOXLkTVwDvhvKXHW_HX0tu9brO_fid5Y7UXkSOkiqAN8NrFLE7TpGlrVpXJk54QlPBAnjR2cjQVIzz2hhd7QDYHaO5buPPvzMnhEvFxr9WfA1Lnw8m-cej0w-b8LgzH05itgULTd3aV-hCNWrbD5LfsCsV1w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Observational+studies+on+macroprolactin+in+a+routine+clinical+laboratory&rft.jtitle=Clinical+chemistry+and+laboratory+medicine&rft.au=Barth%2C+Julian+H&rft.au=Lippiatt%2C+Carys+M&rft.au=Gibbons%2C+Stephen+G&rft.au=Desborough%2C+Robert+A&rft.date=2018-07-26&rft.issn=1437-4331&rft.eissn=1437-4331&rft.volume=56&rft.issue=8&rft.spage=1259&rft_id=info:doi/10.1515%2Fcclm-2018-0074&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1434-6621&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1434-6621&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1434-6621&client=summon |